Market Overview - U.S. stock futures declined slightly after major indices posted gains for two consecutive days [1] - The Dow Jones, S&P 500, Nasdaq 100, and Russell 2000 all showed minor declines in premarket trading [4] Economic Data - U.S. Final GDP for Q3 was reported at 4.4%, exceeding estimates of 4.3% [2] - The Personal Consumption Expenditures (PCE) price index increased by 2.8% year-over-year, aligning with expectations [2] - The 10-year Treasury bond yield was at 4.23%, while the two-year bond yield was at 3.60% [3] - Market expectations indicate a 95% likelihood that the Federal Reserve will maintain current interest rates in January [3] Stocks in Focus - Capital One Financial Corp.: Shares fell 3.31% in pre-market trading after Q4 results missed analyst estimates [6] - Revelation Biosciences Inc.: Stock surged 38.11% after announcing an agreement with the FDA for its drug Gemini [6] - Intel Corp.: Shares dropped over 12% due to a weak Q1 outlook that fell short of expectations [6] - CSX Corp.: Stock rose 2.99% despite missing consensus estimates on both revenue and earnings [6] Sector Performance - Energy, materials, consumer discretionary, and health care sectors led gains in the S&P 500 on Thursday [7] Analyst Insights - Bank of America's fund manager survey indicates institutional investors are the most bullish since 2021, with 38% expecting stronger global growth [9] - The survey included 196 participants managing $575 billion in assets, showing a significant increase in equity allocations [9] - BofA's Bull & Bear Indicator rose to 9.4, indicating high optimism in the market [10] Commodities and Crypto - Crude oil futures increased by 1.03% to approximately $59.97 per barrel [11] - Gold Spot price rose by 0.19% to around $4,918.76 per ounce [11] - Bitcoin traded 0.40% lower at $89,258.41 per coin [11]
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Decline After 2 Consecutive Days Of Gains—Intel, CSX In Focus